Received Sep 23, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEPA | HEP A (HAVRIX) | GLAXOSMITHKLINE BIOLOGICALS | 2 | 42DM9 | IM / RL |
Patient received second Hepatitis A vaccine on July 1, 2025 at 16 months old-only 4 months after first Hepatitis A vaccine that was administered on March 7, 2025 at 12 months old. No adverse reaction or symptoms reported.
None reported
None reported
None
None
None